Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-16

FDA Approved: MOVANTIK — Original Application (RedHill Biopharma Ltd)

View source ↗

Summary

FDA approved Movantik (naloxegol oxalate) through an Original Application for the treatment of opioid-induced constipation in adults with chronic noncancer pain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOVANTIK (Naloxegol oxalate)

Snippet

ORIG AP for MOVANTIK (NALOXEGOL OXALATE)